Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator Survey.

burnout neuro-oncology young investigator

Journal

Neuro-oncology practice
ISSN: 2054-2577
Titre abrégé: Neurooncol Pract
Pays: England
ID NLM: 101640528

Informations de publication

Date de publication:
Aug 2024
Historique:
pmc-release: 13 03 2025
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: epublish

Résumé

Burnout is a syndrome characterized by emotional exhaustion, depersonalization, and a reduced sense of accomplishment, which commonly arises from chronic workplace stress in the medical field. Given the higher risk of burnout in younger age groups reported in some studies, the Society for Neuro-Oncology (SNO) Young Investigator (YI) and Wellness Committees combined efforts to examine burnout in the SNO YI membership to better understand and address their needs. We distributed an anonymous online survey to SNO members in 2019. Only those meeting the definition of a YI were asked to complete the survey. The survey consisted of questions about personal and professional characteristics as well as the validated Maslach Burnout Inventory-Human Services Survey (MBI-HSS) questionnaire. Statistical analyses included descriptive statistics, univariate and multivariate analyses, and incorporation of previously defined burnout profiles. Data were analyzed for 173 participants who self-identified as YI. Measures of burnout showed that YI members scored higher on emotional exhaustion and depersonalization compared to normative population but similar to those in a prior SNO general membership survey. With respect to burnout profiles, 30% of YI respondents classified as overextended and 15% as burnout. Organizational challenges were the most common contributors to stress. Similar to results from a previous survey completed by general SNO membership, the prevalence of burnout among neuro-oncology clinical and research YI is high, and is mainly characterized by overextension, warranting interventions at institutional and organizational levels.

Sections du résumé

Background UNASSIGNED
Burnout is a syndrome characterized by emotional exhaustion, depersonalization, and a reduced sense of accomplishment, which commonly arises from chronic workplace stress in the medical field. Given the higher risk of burnout in younger age groups reported in some studies, the Society for Neuro-Oncology (SNO) Young Investigator (YI) and Wellness Committees combined efforts to examine burnout in the SNO YI membership to better understand and address their needs.
Methods UNASSIGNED
We distributed an anonymous online survey to SNO members in 2019. Only those meeting the definition of a YI were asked to complete the survey. The survey consisted of questions about personal and professional characteristics as well as the validated Maslach Burnout Inventory-Human Services Survey (MBI-HSS) questionnaire. Statistical analyses included descriptive statistics, univariate and multivariate analyses, and incorporation of previously defined burnout profiles.
Results UNASSIGNED
Data were analyzed for 173 participants who self-identified as YI. Measures of burnout showed that YI members scored higher on emotional exhaustion and depersonalization compared to normative population but similar to those in a prior SNO general membership survey. With respect to burnout profiles, 30% of YI respondents classified as overextended and 15% as burnout. Organizational challenges were the most common contributors to stress.
Conclusions UNASSIGNED
Similar to results from a previous survey completed by general SNO membership, the prevalence of burnout among neuro-oncology clinical and research YI is high, and is mainly characterized by overextension, warranting interventions at institutional and organizational levels.

Identifiants

pubmed: 39006527
doi: 10.1093/nop/npae018
pii: npae018
pmc: PMC11241357
doi:

Types de publication

Journal Article

Langues

eng

Pagination

494-506

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Déclaration de conflit d'intérêts

The authors do not have any conflicts of interest to declare.

Auteurs

Gilbert Youssef (G)

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Alvina Acquaye-Mallory (A)

Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Elizabeth Vera (E)

Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Milan G Chheda (MG)

Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.

Gavin P Dunn (GP)

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Jennifer Moliterno (J)

Yale School of Medicine, Chenevert Family Brain Tumor Center, Yale Cancer Center and Smilow Cancer Hospital, New Haven, Connecticut, USA.

Barbara J O'Brien (BJ)

Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Monica Venere (M)

Department of Radiation Oncology, James Cancer Hospital and Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Tzagournis Medical Research Facility, Columbus, Ohio, USA.

Shlomit Yust-Katz (S)

Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center and Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Eudocia Q Lee (EQ)

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Terri S Armstrong (TS)

Neuro-Oncology Branch, Center for Cancer Research, The National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Classifications MeSH